当前位置:
X-MOL 学术
›
Ann. Hematol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Trametinib and Dabrafenib in histiocytic sarcoma transdifferentiated from chronic lymphocytic leukemia with a K-RAS and a unique BRAF mutation.
Annals of Hematology ( IF 3.0 ) Pub Date : 2020-02-03 , DOI: 10.1007/s00277-020-03941-7 George Z Rassidakis 1, 2 , Olga Stromberg 3 , Ioanna Xagoraris 2 , Kenbugul Jatta 1 , Kristina Sonnevi 3
中文翻译:
Trametinib和Dabrafenib在具有K-RAS和独特BRAF突变的慢性淋巴细胞性白血病转分化的组织细胞肉瘤中。
更新日期:2020-02-03
Annals of Hematology ( IF 3.0 ) Pub Date : 2020-02-03 , DOI: 10.1007/s00277-020-03941-7 George Z Rassidakis 1, 2 , Olga Stromberg 3 , Ioanna Xagoraris 2 , Kenbugul Jatta 1 , Kristina Sonnevi 3
Affiliation
中文翻译:
Trametinib和Dabrafenib在具有K-RAS和独特BRAF突变的慢性淋巴细胞性白血病转分化的组织细胞肉瘤中。